UB Paderborn / Katalog / Suche / in CDI

Prevalence of potential drug―drug interactions in cancer patients treated with oral anticancer drugs

British journal of cancer, 2013-03, Vol.108 (5), p.1071-1078

2013

Volltextzugriff (PDF)

Burden of early, advanced and metastatic breast cancer in The Netherlands

BMC cancer, 2018-03, Vol.18 (1), p.262-262, Article 262

2018

Volltextzugriff (PDF)

Drug–drug interactions in patients treated for cancer: a prospective study on clinical interventions

Annals of oncology, 2015-05, Vol.26 (5), p.992-997

2015

Volltextzugriff (PDF)

Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance

European journal of clinical pharmacology, 2024-03, Vol.80 (3), p.455-464

2024

Volltextzugriff (PDF)

High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study

Supportive care in cancer, 2022-01, Vol.30 (1), p.271-278

2022

Volltextzugriff (PDF)

Assessing the binding interaction of polystyrene sulfonate with amitriptyline in healthy volunteers: a cross-over design — The BIND study

European journal of clinical pharmacology, 2022-05, Vol.78 (5), p.839-845

2022

Volltextzugriff (PDF)

Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer

Clinical pharmacokinetics, 2023-07, Vol.62 (7), p.989-996

2023

Volltextzugriff (PDF)

Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study: Potential novel binding interactions with resins

International journal of clinical pharmacy, 2022-04, Vol.44 (2), p.389-398

2022

Volltextzugriff (PDF)

Identifying patients with metformin associated lactic acidosis in the emergency department

International journal of clinical pharmacy, 2020-10, Vol.42 (5), p.1286-1292

2020

Volltextzugriff (PDF)

Reply to the letter to the editor ‘Potential clinical relevant drug–drug interactions: comparison between different compendia, do we have a validated method?’ by Conde-Estévez et al

Annals of oncology, 2015-06, Vol.26 (6), p.1272-1273

2015

Volltextzugriff (PDF)

Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations

Journal of clinical pharmacy and therapeutics, 2018-08, Vol.43 (4), p.574-577

2018

Volltextzugriff (PDF)

Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study

International journal of clinical pharmacy, 2022-04, Vol.44 (2), p.389-398

2022

Volltextzugriff (PDF)

Novel online drug-drug interaction resource reveals clinically relevant interactions in>20% of the searches

Annals of oncology, 2018-10, Vol.29, p.viii638-viii638

2018

Volltextzugriff (PDF)

Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands

Journal of medical economics, 2017-12, Vol.20 (12), p.1231-1236

2017

Volltextzugriff (PDF)

Increase of baclofen intoxications: risks involved and management

Netherlands journal of medicine, 2014-11, Vol.72 (9), p.497-499

2014

Volltextzugriff (PDF)

2048P Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer

Annals of oncology, 2023-10, Vol.34, p.S1084-S1084

2023

Volltextzugriff (PDF)

Acute intoxication patients presenting to an emergency department in the Netherlands: admit or not? Prospective testing of two algorithms

Emergency medicine journal : EMJ, 2012-06, Vol.29 (6), p.467-472

2012

Volltextzugriff (PDF)

Crushed prednisolone tablets or oral solution for acute asthma?

Archives of disease in childhood, 2001-04, Vol.84 (4), p.347-348

2001

Volltextzugriff (PDF)

Costs of Chemotherapy in the Treatment of Colorectal Cancer

The European journal of health economics, 2006-06, Vol.7 (2), p.145-146

2006

Volltextzugriff (PDF)

731P The impact of proton pump inhibitors on pazopanib exposure

Annals of oncology, 2020-09, Vol.31, p.S571-S572

2020

Volltextzugriff (PDF)

Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer

Drug safety, 2001, Vol.24 (5), p.353-367

2001

Volltextzugriff (PDF)

Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer

Drug safety, 2000-10, Vol.23 (4), p.255-278

2000

Volltextzugriff (PDF)

In vivo pharmacokinetics of a gentamicin-loaded collagen sponge in acute periprosthetic infection: Serum values in 19 patients

Acta orthopaedica, 2008-01, Vol.79 (5), p.637-642

2008

Volltextzugriff (PDF)

Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands

Clinical therapeutics, 2004-04, Vol.26 (4), p.579-589

2004

Volltextzugriff (PDF)

Reply to the letter to the editor 'Potential clinical relevant drug-drug interactions: comparison between different compendia, do we have a validated method?' by Conde-Estévez et al

Annals of oncology, 2015-06, Vol.26 (6), p.1272

2015

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Prevalence of potential drug―drug interactions in cancer patients treated with oral anticancer drugs

Burden of early, advanced and metastatic breast cancer in The Netherlands

Drug–drug interactions in patients treated for cancer: a prospective study on clinical interventions

Drug-drug interaction perpetrators of oxycodone in patients with cancer: frequency and clinical relevance

High prevalence of peripheral neuropathy in multiple myeloma patients and the impact of vitamin D levels, a cross-sectional study

Assessing the binding interaction of polystyrene sulfonate with amitriptyline in healthy volunteers: a cross-over design — The BIND study

Enzalutamide Reduces Oxycodone Exposure in Men with Prostate Cancer

Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study: Potential novel binding interactions with resins

Identifying patients with metformin associated lactic acidosis in the emergency department

Reply to the letter to the editor ‘Potential clinical relevant drug–drug interactions: comparison between different compendia, do we have a validated method?’ by Conde-Estévez et al

Dosing oxaliplatin in a haemodialysis patient with metastatic rectum cancer monitored by free platinum concentrations

Exploring co-dispensed drug use in patients on sevelamer or polystyrene sulfonate to identify potential novel binding interactions: a cross sectional in silico study

Novel online drug-drug interaction resource reveals clinically relevant interactions in>20% of the searches

Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands

Increase of baclofen intoxications: risks involved and management

2048P Frequency and clinical relevance of drug-drug interactions with oxycodone among patients with cancer

Acute intoxication patients presenting to an emergency department in the Netherlands: admit or not? Prospective testing of two algorithms

Crushed prednisolone tablets or oral solution for acute asthma?

Costs of Chemotherapy in the Treatment of Colorectal Cancer

731P The impact of proton pump inhibitors on pazopanib exposure

Management of chemotherapy-induced adverse effects in the treatment of colorectal cancer

Risk factors determining chemotherapeutic toxicity in patients with advanced colorectal cancer

In vivo pharmacokinetics of a gentamicin-loaded collagen sponge in acute periprosthetic infection: Serum values in 19 patients

Cost-benefit analysis of capecitabine versus 5-fluorouracil/leucovorin in the treatment of colorectal cancer in the Netherlands

Reply to the letter to the editor 'Potential clinical relevant drug-drug interactions: comparison between different compendia, do we have a validated method?' by Conde-Estévez et al

Suchergebnisse filtern